At a glance
ClinicalIndex Comparison RecordN/ACompleted· 79 enrolled
Drug / intervention
HairMax LaserComb +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Control Device Clinical Trial to Evaluate the Safety and Efficacy of the HairMax LaserComb 2009, 9 & 12 Beam Models: For the Treatment of Androgenetic Alopecia in Males
In Brief
A clinical study evaluating HairMax LaserComb and Control device for Androgenetic Alopecia and 2 related conditions. Completed, enrolled 79 participants across 3 sites.
Detailed Summary
The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAndrogenetic Alopecia, Hair Loss, Male Pattern Baldness
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedJul 2009
Primary CompletionAug 2010
TodayJul 2026
First PostedJul 28, 2009
Enrollment StartJul 1, 2009
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.9 years ago
Interventions
HairMax LaserCombdevice
Device application 3 times week (non-consecutive days), for 26 weeks
Control devicedevice
Device is used 3 times a week on non-consecutive days